Utah Medical Products Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	10.49	11.29	13.87	16.64	16.47	14.79
Depreciation & Amortization	2.46	3.01	2.85	6.37	7.08	7.28
Stock-Based Compensation	0.4	0.37	0.26	0.23	0.18	0.17
Provision & Write-off of Bad Debts	0.36	0.37	-0	-0.03	0.03	0.02
Other Operating Activities	-0.48	-0.66	-0.36	-0.69	-0.4	-0.09
Change in Accounts Receivable	-0.13	0.34	-0.84	2.27	-0.51	-1.09
Change in Inventory	-0.84	1.2	0.59	-0.67	-2.35	-0.49
Change in Accounts Payable	0.14	0.21	-0.07	-0.46	0.46	-0.02
Change in Other Net Operating Assets	-0.55	-1.43	-1.48	-1.38	0.17	0.59
Operating Cash Flow	11.85	14.69	14.83	22.28	21.15	21.2
Operating Cash Flow Growth	-16.16%	-0.94%	-33.44%	5.36%	-0.26%	5.29%
Capital Expenditures	-0.4	-0.37	-0.23	-0.64	-0.81	-0.55
Sale of Property, Plant & Equipment	-	-	0.03	-	-	-
Sale (Purchase) of Intangibles	-	-	-0.01	-	-0.01	-
Investing Cash Flow	-0.4	-0.37	-0.21	-0.64	-0.82	-0.55
Issuance of Common Stock	-	-	0.39	0.12	0.17	0.56
Repurchase of Common Stock	-1.85	-8.36	-19.97	-	-2.5	-
Common Dividends Paid	-3.94	-3.98	-4.26	-4.28	-3.16	-11.47
Financing Cash Flow	-5.79	-12.34	-23.84	-4.17	-5.48	-10.91
Foreign Exchange Rate Adjustments	-0.3	0.8	-0.68	0.34	-0.77	-0.36
Net Cash Flow	5.35	2.78	-9.89	17.82	14.08	9.38
Free Cash Flow	11.45	14.32	14.6	21.64	20.34	20.65
Free Cash Flow Growth	-17.03%	-1.92%	-32.53%	6.41%	-1.52%	7.13%
Free Cash Flow Margin	31.70%	37.18%	35.70%	43.09%	38.90%	42.10%
Free Cash Flow Per Share	3.58	4.42	4.17	5.95	5.58	5.64
Levered Free Cash Flow	8.84	11.13	11.79	16.66	18.35	17.14
Unlevered Free Cash Flow	8.84	11.13	11.79	16.66	18.35	17.14
Cash Income Tax Paid	3.34	4	4.64	4.83	4.97	4.62
Change in Working Capital	-1.38	0.32	-1.8	-0.23	-2.23	-1.01

SEC Filings: 10-K · 10-Q